Mary Beckerle

Last updated
Mary Beckerle in 2012 Mary Beckerle.jpg
Mary Beckerle in 2012

Mary C. Beckerle is an American cell biologist who studies cancer at the Huntsman Cancer Institute at the University of Utah School of Medicine. At Huntsman Cancer Institute, she serves as the CEO and also as Associate Vice President for Cancer Affairs at the University of Utah. Beckerle's research helped to define a novel molecular pathway for cell motility, and more recently, she has begun research into Ewing’s sarcoma, a pediatric bone cancer. Beckerle's lab made a ground breaking discovery in regards to Ewing's Sarcoma in relation to the EWS/FLI protein. [1] Her lab discovered EWS/FLI to disrupt the internal cellular skeleton, which decreases the ability of cells to adhere to their proper environment. This can help explain the metastasis of tumors in patients with Ewing's sarcoma.

Contents

Early life

Mary Catherine Beckerle was born in Rivers Edge, New Jersey to Martin and Mickey Beckerle. She is the oldest of three daughters. Her father worked at the New York Telephone Co. and died at the age of 36 of emphysema. [2] Her mother was a registered nurse. After high school, Beckerle attended Wells College in New York, where she earned a B. A. in Biology and Psychology. [2] She graduated magna cum laude and was a member of Phi Beta Kappa. [3] Before continuing her education, she took a year off and worked in a cellular biology research laboratory at University of Texas Southwest Medical Center. After this, she attended the University of Colorado Boulder where she earned a PhD. in Molecular Biology. Her education then continued at the University of North Carolina Chapel Hill where she was a postdoctoral fellow in Anatomy and Cell Biology. [1]

Personal life

While at the University of North Carolina Chapel Hill, Beckerle met David Murrell. She would go on to marry him. The couple shares one son. [3]

Career

Beckerle joined the University of Utah faculty as an assistant professor of biology. She continued at the University of Utah and was one of the first professors to move into the Huntsman Cancer Institute when it opened in 1999. Also in 1999, she was awarded the Ralph E. and Willa T. Main Presidential Endowed Chair in Cancer Research at the University of Utah. [4] She led a program specializing in cancer cell biology until 2003. In 2003, she was named the deputy director of the center. In 2006, she was named the CEO and the director of Huntsman Cancer Institute. In 2009, she was also named the Associate Vice President for Cancer Affairs at the University of Utah. She holds the Jon M. Huntsman Presidential Endowed Chair at the University of Utah, where she has also been promoted to a distinguished professorship in the biology department. [5]

In 1990, Beckerle served on the editorial board of Molecular Biology of the cell. [3] She was awarded a Guggenheim Fellowship in Molecular and Cellular Biology at the Curie Institute in Paris in 1999. [6] In 2006, Beckerle served as the president of the American Society of Cell Biology. She was elected to the American Academy of Arts and Sciences in 2008. [4] In 2013, she was elected to the Board of Directors of the American Association for Cancer Research. [7] Beckerle was elected to the American Philosophical Society in the April 2017 group of inductees that also included Barack Obama. [8] [9] She was on the Life Sciences jury for the Infosys Prize in 2020. [10]

She is a member of the U. S. National Academy of Sciences. [11]

2017 Huntsman Cancer Institute Firing and Reinstatement

On 17 April 2017, Beckerle was terminated as CEO and Director of the Huntsman Cancer Institute via an email from University of Utah President David W. Pershing and Senior Vice President for Health Sciences Vivian Lee. The university did not disclose reasons for the dismissal, but members of the Huntsman family issued several public criticisms of the move, and called for Beckerle's reinstatement while criticizing the leadership shown by Pershing and Lee. [12] [13] In subsequent days, members of the family made media appearances, published full page newspaper ads reiterating their support for cancer research and Beckerle, and even called for the termination of top university officials. [14] Beckerle's firing occurred as the University of Utah and Huntsman Cancer Foundation were negotiating terms for a new memorandum of understanding to govern the operations of Huntsman Cancer Institute. [15] Some Huntsman Cancer Institute faculty and staff were among over 3600 individuals who signed a petition requesting Beckerle be restored to her position. On 19 April, roughly 100 demonstrators marched from the Huntsman Cancer Institute facilities across the university campus to the Office of President Pershing, calling for Beckerle's return. This came on the heels of other meetings and protests in the university community. On the morning of 25 April, the university's board of trustees met in a closed session, after which Pershing briefly spoke to reporters, mentioning that an announcement would be forthcoming later in the day. Within a few hours, it was announced that Beckerle would be reinstated as CEO and Director of the Huntsman Cancer Institute, and would report directly to the University President, bypassing Vivian Lee. [16] On 28 April, Vivian Lee announced via email that, effective the same day, she was stepping down as the university's senior vice president for health sciences, dean of the medical school, and CEO of the healthcare system. [17] [18]

Research and Ewing’s Sarcoma

Beckerle's research employs several different techniques to exam signaling problems and cell motility issues. Ewing's Sarcoma is a bone cancer affecting mainly children and adolescents. [19] Tumors of Ewing' Sarcoma are typically found in the long bones of the legs and arms, or bones in the chest, trunk, pelvis, back, or head. [20] Beckerle's research in this area focuses on a key pathway as believed to be a mechanism by which the cancer cells can spread. Ewing sarcoma occurs due to a chromosomal mutation that causes an atypical protein, known as EWS/FLI, to be present (also called expressed), and that when EWS/FLI is expressed, literally thousands of genes are misregulated, leading to abnormal behavior. Beckerle's lab found that the EWS/FLI protein disrupted cell adhesion and limited the ability of cells to remain in their normal environment. The EWS/FLI protein is difficult to regulate so Beckerle's team is focused on an essential regulating protein called lysine specific demethylase (LSD1). Preliminary research has aimed to halt the function of LSD1 to prevent the spread of Ewing Sarcoma cells. [1]

Selected publications

Related Research Articles

<span class="mw-page-title-main">Desmoplastic small-round-cell tumor</span> Aggressive and rare cancer

Desmoplastic small-round-cell tumor (DSRCT) is an aggressive and rare cancer that primarily occurs as masses in the abdomen. Other areas affected may include the lymph nodes, the lining of the abdomen, diaphragm, spleen, liver, chest wall, skull, spinal cord, large intestine, small intestine, bladder, brain, lungs, testicles, ovaries, and the pelvis. Reported sites of metastatic spread include the liver, lungs, lymph nodes, brain, skull, and bones. It is characterized by the EWS-WT1 fusion protein.

<span class="mw-page-title-main">Huntsman Cancer Institute</span> Hospital in Utah, United States

Huntsman Cancer Institute (HCI) is an NCI-designated cancer research facility and hospital located on the campus of the University of Utah in Salt Lake City, Utah. It is the only National Cancer Institute-designated Comprehensive Cancer Center in the Intermountain West.

<span class="mw-page-title-main">Ewing sarcoma</span> Type of cancer

Ewing sarcoma is a type of cancer that forms in bone or soft tissue. Symptoms may include swelling and pain at the site of the tumor, fever, and a bone fracture. The most common areas where it begins are the legs, pelvis, and chest wall. In about 25% of cases, the cancer has already spread to other parts of the body at the time of diagnosis. Complications may include a pleural effusion or paraplegia.

<span class="mw-page-title-main">FLI1</span> Protein-coding gene in the species Homo sapiens

Friend leukemia integration 1 transcription factor (FLI1), also known as transcription factor ERGB, is a protein that in humans is encoded by the FLI1 gene, which is a proto-oncogene.

<span class="mw-page-title-main">CD99</span> Protein-coding gene in humans

CD99 antigen, also known as MIC2 or single-chain type-1 glycoprotein, is a heavily O-glycosylated transmembrane protein that is encoded by the CD99 gene in humans. The protein has a mass of 32 kD. Unusually for a gene present on the X chromosome, the CD99 gene does not undergo X inactivation, and it was the first such pseudoautosomal gene to be discovered in humans.

<span class="mw-page-title-main">ETV4</span> Protein-coding gene in the species Homo sapiens

ETS translocation variant 4 (ETV4), also known as polyoma enhancer activator 3 (PEA3), is a member of the PEA3 subfamily of Ets transcription factors.

<span class="mw-page-title-main">RNA-binding protein EWS</span> Human protein and coding gene

RNA-binding protein EWS is a protein that in humans is encoded by the EWSR1 gene on human chromosome 22, specifically 22q12.2. It is one of 3 proteins in the FET protein family. The q22.2 region of chromosome 22 encodes the N-terminal transactivation domain of the EWS protein and that region may become joined to one of several other chromosomes which encode various transcription factors, see and the FET protein family. The expression of a chimeric protein with the EWS transactivation domain fused to the DNA binding region of a transcription factor generates a powerful oncogenic protein causing Ewing sarcoma and other members of the Ewing family of tumors. These translocations can occur due to chromoplexy, a burst of complex chromosomal rearrangements seen in cancer cells. The normal EWS gene encodes an RNA binding protein closely related to FUS (gene) and TAF15, all of which have been associated to amyotrophic lateral sclerosis.

<i>ERG</i> (gene) Protein-coding gene in the species Homo sapiens

ERG is an oncogene. ERG is a member of the ETS family of transcription factors. The ERG gene encodes for a protein, also called ERG, that functions as a transcriptional regulator. Genes in the ETS family regulate embryonic development, cell proliferation, differentiation, angiogenesis, inflammation, and apoptosis.

<span class="mw-page-title-main">POU4F1</span> Protein-coding gene in the species Homo sapiens

POU domain, class 4, transcription factor 1 (POU4F1) also known as brain-specific homeobox/POU domain protein 3A (BRN3A), homeobox/POU domain protein RDC-1 or Oct-T1 is a protein that in humans is encoded by the POU4F1 gene.

<span class="mw-page-title-main">Small nuclear ribonucleoprotein polypeptide C</span> Protein-coding gene in the species Homo sapiens

U1 small nuclear ribonucleoprotein C is a protein that in humans is encoded by the SNRPC gene.

The Ewing family of tumors (EFTs) is a group of small cell sarcomas including Ewing sarcoma of the bone, extra osseous Ewing tumors, and primitive neuroectodermal tumors. They are rare cancers, usually diagnosed in peoples' twenties. The sarcoma of bone is the most common of the variants. All forms are predisposed to metastasis and have had historically high rates of mortality. The family of tumors shares a common translocation mutation of the EWS gene on chromosome 22 to an ETS-type gene, most commonly the FLI1 gene. EFTs are highly malignant, with 5-year survival for patients with metastatic disease at 20%. The current standard of care includes resection, radiation, and chemotherapy.

<span class="mw-page-title-main">NKX2-2</span> Protein-coding gene in the species Homo sapiens

Homeobox protein Nkx-2.2 is a protein that in humans is encoded by the NKX2-2 gene.

<span class="mw-page-title-main">ETS transcription factor family</span> Protein family

In the field of molecular biology, the ETSfamily is one of the largest families of transcription factors and is unique to animals. There are 29 genes in humans, 28 in the mouse, 10 in Caenorhabditis elegans and 9 in Drosophila. The founding member of this family was identified as a gene transduced by the leukemia virus, E26. The members of the family have been implicated in the development of different tissues as well as cancer progression.

In molecular biology mir-708 microRNA is a short RNA molecule. MicroRNAs function to regulate the expression levels of other genes by several mechanisms. miR-708 is located on chromosome 11q14.1 and is endcoded in intron 1 of the ODZ4 gene. It is most highly expressed in the brain and eyes, and has a supposed role in endoplasmic reticular stress of the eye.

<span class="mw-page-title-main">Vivian Lee</span> American radiologist

Vivian S. Lee is an American radiologist and health care/health technology executive. An Executive Fellow at Harvard Business School and senior lecturer at Harvard Medical School and Massachusetts General Hospital, Lee is the author of the book, The Long Fix: Solving America's Health Care Crisis with Strategies That Work for Everyone. Lee is also a senior fellow at the Institute for Healthcare Improvement (IHI) in Cambridge, Massachusetts. In 2019, she was named No. 11 in Modern Healthcare's 100 Most Influential People in Healthcare and is a frequent speaker at national and international meetings on the applications of big data, AI, and technology in healthcare, leadership and managing change, health equity, and on climate change and health system resilience.

Joan S. Brugge is the Louise Foote Pfeiffer Professor of Cell Biology and the Director of the Ludwig Center at Harvard Medical School, where she also served as the Chair of the Department of Cell Biology from 2004 to 2014. Her research focuses on cancer biology, and she has been recognized for her explorations into the Rous sarcoma virus, extracellular matrix adhesion, and epithelial tumor progression in breast cancer.

David W. Pershing is an American educator and former president of the University of Utah. He received a bachelor's degree from Purdue University in 1970 and a PhD from University of Arizona.

EWS/FLI1 is an oncogenic protein that is pathognomonic for Ewing sarcoma. It is found in approximately 90% of all Ewing sarcoma tumors with the remaining 10% of fusions substituting one fusion partner with a closely related family member.

Andrea A. Hayes Dixon is an American surgeon. She was the first pediatric surgeon to perform a high-risk, life-saving procedure in children with a rare form of cancer and developed the first orthotropic xenograft model of metastatic Ewing's sarcoma. In 2002, she became the first African American female pediatric surgeon board-certified in the United States.

The FET protein family the EWSR1 protein encoded by the EWSR1 gene located at band 12.2 of the long arm of chromosome 22; 2) the FUS protein encoded by the FUS gene located at band 16 on the short arm of chromosome 16; and 3) the TAF15 protein encoded by the TAF15 gene located at band 12 on the long arm of chromosome 7 The FET in this protein family's name derives form the first letters of FUS, EWSR1, and TAF15.

References

  1. 1 2 3 Neufield, Erica. “Huntsman Cancer Institute Awarded Grant for Children's Cancer Research” CureSearch for Children’s Cancer. "Huntsman Cancer Institute Investigator Awarded Grant for Children's Cancer Research: CureSearch". Archived from the original on 2014-12-24. Retrieved 2014-11-26.
  2. 1 2 Benson, Lee, “They all want what Huntsman has — The woman in charge”. Deseret News. March 1, 2014. Accessed November 11, 2014.
  3. 1 2 3 “Mary Beckerle” American Society of Cell Biology. 1994
  4. 1 2 "Huntsman director elected to academy". Deseret News . 2008-04-30.
  5. "Mary C. Beckerle, PhD - Faculty Details - U of U School of Medicine - | University of Utah".
  6. "John Simon Guggenheim Foundation | Mary C. Beckerle".
  7. Mary Beckerle. Huntsman Cancer Institute
  8. "Newly Elected – April 2017". amphilsoc.org. American Philosophical Society. Archived from the original on 15 September 2017. Retrieved 23 May 2017.
  9. "Huntsman Cancer Institute CEO inducted into American Philosophical Society". deseretnews.com. Deseret News. 22 May 2017. Retrieved 22 May 2017.
  10. "Infosys Prize - Jury 2020". www.infosys-science-foundation.com. Retrieved 2020-12-10.
  11. "News from the National Academy of Sciences". 2021-04-26. Retrieved 2021-07-01. Newly elected members and their affiliations at the time of election are: ... Beckerle, Mary C.; chief executive officer and director, Huntsman Cancer Institute; and distinguished professor of biology and associate vice president for cancer affairs, University of Utah, Salt Lake City
  12. "Huntsman says University of Utah 'power grab' is behind firing of acclaimed researcher from cancer institute top post".
  13. "Huntsman Sr. Blasts the U. For firing of Cancer Institute director, says there is 'no excuse' for it".
  14. "Huntsman calls for 'inept' U. Administrators to be fired over cancer institute CEO's termination".
  15. "Emails explain clash between Huntsmans and the U. Over Huntsman Cancer Institute CEO's firing".
  16. "In major reversal, U. Reinstates fired Huntsman Cancer Institute CEO".
  17. "U. Health Care CEO Vivian Lee resigns after cancer institute controversy".
  18. "Dr. Vivian Lee resigns post at University of Utah".
  19. Ewing Sarcoma. St’ Jude’s Children’s Hospital
  20. Ewing’s Sarcoma. WebMD